December 5th 2024
A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
This Consult has been endorsed by the American College of Obstetricians and Gynecologists (ACOG) and replaces the Society for Maternal-Fetal Medicine's (SMFM) Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
Read More
History of spontaneous abortion linked to increased risk of gestational diabetes
March 8th 2022An analysis of data from more than 100k pregnant women suggests a history of spontaneous abortion was associated with an 18% increase in risk of subsequent gestational diabetes, with a history of multiple spontaneous abortions associated with an even greater risk.
Read More
Impact of dual burden differs by insurance type
February 18th 2022Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.
Read More
A digital decision aid for shared decision-making in prenatal counseling
February 10th 2022Because the treatment options for imminent extreme premature labor center largely on patient preference, decision aids (DA) can help facilitate the patient-provider discussion and guide the shared decision-making process.
Read More
ICD-10-CM Diagnosis Codes for 2022
February 8th 2022Effective each year on October 1, additions, deletions, and updates to the ICD-10-CM code set are published. This year, no significant changes were made to Chapter 15, the obstetrics chapter. However, there are a few new codes that could affect the practice of maternal-fetal medicine.
Read More
Marijuana exposure during pregnancy may increase adverse birth outcomes
February 8th 2022A review and meta-analysis in JAMA Network Open revealed women exposed to marijuana in pregnancy were at significantly increased risk for adverse neonatal outcomes, including low birth weight, small for gestational age, and preterm delivery.
Read More
Supporting transgender and gender-expansive individuals in reproductive health care
February 4th 2022At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.
Read More
Protocols for High-Risk Pregnancies, 7th Edition Prenatal testing for chromosomal abnormalities
February 3rd 2022Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.
Read More
The effect of eating disorders in pregnancy on neurodevelopmental risk in infants
January 24th 2022Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Read More
Mirvie RNA test aims to predict pregnancy complications
January 13th 2022Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
Watch
MiPATH Prenatal Care Recommendations: a how-to guide for maternity care professionals
Together, the American College of Obstetrics & Gynecologists (ACOG) and the University of Michigan developed MiPATH recommendations (Michigan Plan for Appropriate Tailored Healthcare) to create comprehensive, tailored prenatal care plans for patients.
Read More
Maternal nativity and disparities in preeclampsia
January 6th 2022A cross-sectional analysis of the Boston Birth Cohort (BBC) from 1998 to 2016 has found that maternal nativity and duration of United States residence were linked to preeclampsia among non-Hispanic Black women, but not among Hispanic and non-Hispanic White women, after adjusting for sociodemographic and cardiovascular risk factors.
Read More